Jan 13, 2026 07:01AM
Jan 13, 2026 07:00AM
Jan 6, 2026 07:00AM
Dec 11, 2025 04:01PM
Dec 11, 2025 04:01PM
Dec 9, 2025 11:30PM
Dec 9, 2025 11:30PM Kymera Therapeutics Announces Pricing of Upsized $602 Million Public Offering
Dec 8, 2025 04:01PM
Dec 8, 2025 04:01PM
Jun 26, 2025 11:56PM
Jun 25, 2025 04:06PM
Jun 25, 2025 04:05PM
Jan 14, 2025 07:01AM
Jan 14, 2025 07:00AM Kymera Therapeutics Outlines Key 2025 Objectives and Strategy to Advance Industry Leading Portfolio of Oral Immunology Programs
Jan 7, 2025 07:00AM
Nov 5, 2024 07:00AM
Aug 21, 2024 11:15AM
Aug 20, 2024 06:12AM
Aug 19, 2024 10:45PM
Aug 19, 2024 04:01PM
Aug 19, 2024 04:01PM Kymera Therapeutics Announces Proposed Public Offering
Jan 9, 2024 09:17AM
Jan 9, 2024 09:15AM
Jan 5, 2024 06:00AM
Jan 5, 2024 06:00AM
Jan 4, 2024 04:01PM
Jan 4, 2024 04:01PM
Jan 2, 2024 07:00AM Kymera Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 9, 2024
Nov 1, 2023 07:00AM
May 4, 2023 07:00AM
Jan 10, 2023 07:07AM
Jan 10, 2023 07:00AM
Jan 10, 2023 07:00AM
Jan 3, 2023 07:00AM
Jan 3, 2023 07:00AM Kymera Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference on Tuesday, January 10, 2023
Mar 10, 2022 04:24AM
Jan 10, 2022 07:00AM
Jan 10, 2022 07:00AM
Jan 4, 2022 08:00AM
Jan 4, 2022 08:00AM
Nov 10, 2021 07:00AM
Nov 10, 2021 07:00AM Kymera Therapeutics Announces Third Quarter 2021 Financial Results and Provides a Business Update
Jul 6, 2021 04:00PM
Jul 6, 2021 04:00PM
Jul 1, 2021 04:48AM
Jun 30, 2021 09:45PM
Jun 30, 2021 09:45PM
Jun 28, 2021 04:39PM
Jun 28, 2021 04:36PM Kymera Therapeutics Announces Proposed Public Offering of Common Stock
Jun 28, 2021 04:36PM

276,561 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All